Corona Virus Health Indian Subcontinent Life Science Opinion

Reason for snail phase of vaccination in India revealed by ICMR Dr. Arora

Covid-19 vaccination pace deliberately kept low, explains ICMR doctor  One-third of those who have already contracted Covid-19 do not develop antibodies required, Dr NK Arora explained.  Taking questions from social media users, Indian Council of Medical Research’s Dr NK Arora on Friday clarified several issues regarding Covid-19 vaccination.  Union health ministry shared those video messages Read More…

America Corona Virus Life Science medical

Scientists maps “molecular activities on viral infection” resulted in new drugs to Combat Covid-19

Following months of interdisciplinary research assessing tens of thousands of lung cells infected with the novel coronavirus, scientists have created one of the most comprehensive maps to date of the molecular activities that are triggered inside these cells at the onset of the viral infection, an advance that may lead to the development of new Read More…

Companies Corona Virus West India

Serum Institue fire 5 charred to death cause of fire unknown

  Serum Institute Manjari facility in Pune is where the Covishield vaccine used in the nationwide inoculation drive against the pandemic is made.   The building where the fire broke out is part of the under-construction site of the Serum facility and Covishield production has not been affected by the fire, sources said.   So Read More…

Asia China Corona Virus Pakistan

In Line with UAE, Bahrain , Pakistan also approves Chinese Sinopharm vaccine

Two Arab nations have become the first countries to approve a Chinese COVID-19 vaccine, a significant boost for China’s plans to roll out its vaccines worldwide.   The United Arab Emirates (UAE) approved a vaccine developed by Chinese state-owned Sinopharm on 9 December, and Bahrain followed days later   Following suit Asean country Pakistan on Read More…

Companies Corona Virus Indian Subcontinent Life Science Life Style medical

BharatBiotech says Covaxin is to be administered subject to Conditions apply clauses

The move to include Covaxin even before the publication of data from its phase 3 trial had come under criticism from some quarters.   However, the regulator had defended the decision by saying that both the vaccines were totally safe.   Over 500 adverse reactions were reported from across the country during two days of Read More…

Corona Virus Indian Subcontinent Life Science medical

Indians so far 3.8 lakhs vaccinated and 580 found adverse effect : Health Ministry

In india a total of 3,81,305 beneficiaries have so far been vaccinated for coronavirus, even as 580 adverse events following immunization were reported in the country, the Union Health Ministry said on Monday.   Yesterday, for the first time, active cases declined below 2 per cent of the total cases reported in the country.   Read More…

Corona Virus Indian Subcontinent Life Science

Covid-19 Phase 1 vaccination will kick-off on January 16 across India

The much-awaited Covid-19 vaccination drive will kick-off on January 16. Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively.   “As many as Read More…

Corona Virus Health Indian Subcontinent Industries Life Science medical Regulators

Medical Experts questions swift approval of 2 vaccines and ask for data

Healthcare experts on Monday 4 January questioned the government’s assertion that Bharat Biotech’s COVID-19 vaccine Covaxin can target mutated coronavirus strains and maybe used us a ”backup”, as they asked for the scientific basis for the claim and for the vaccine’s safety and efficacy.   India’s country drugs regulator Sunday granted emergency use approval to Read More…

Corona Virus Indian Subcontinent Industries Life Science medical

Bharat Biotech’s vaccine also got approval for roll-out of COVID-19 shots

The recommendation for Bharat Biotech’s vaccine came a day after the panel cleared the Serum Institute of India’s emergency use athorisation application for the Oxford-AstraZeneca vaccine Covishield, paving the way for the roll-out of COVID-19 shots in the country in the next few days. The Union Health Ministry on Saturday also confirmed that the Subject Read More…

America Corona Virus Health Indian Subcontinent medical

After vaccine , if tested positive for Covid-19 is dangerous or not , what Experts say

A nurse in California tested positive for COVID-19 eight days after receiving the first dose of the Pfizer vaccine approved for emergency use in the US.   Matthew W., 45, talked about receiving the vaccine on December 18 in a Facebook post, said the report on Tuesday.   He told ABC 10News that he suffered Read More…